✉ Email this page to a colleague
« Back to Dashboard
Filibuvir is an investigational drug.
There have been 4 clinical trials for Filibuvir. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Hepatitis C, Hepatitis, and Hepatitis, Chronic. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Recent Clinical Trials for Filibuvir
|Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance||Pfizer||Phase 1|
|Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol)||Pfizer||Phase 1|
|A Study To Investigate Safety And Pharmacokinetics Of A Single Dose Of PF-00868554 (Filibuvir) In Japanese Healthy Adult Volunteers||Pfizer||Phase 1|